Detalhe da pesquisa
1.
An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma.
Contemp Oncol (Pozn)
; 27(3): 139-146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239862
2.
High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.
Front Oncol
; 13: 1250355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829335